Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma: analysis of REACH trial results by Child-Pugh Score - Zhu, A X; Baron, A D; Malfertheiner, P (JAMA Oncol, 2016)
[Epub ahead of print]